With Trump’s Return, Pharma Trades Disagreeable Knowns For Uncertainty
Drug pricing policies, M&A oversight, FDA and HHS leadership, the Biosecure Act and tariffs are among the many issues pharmaceutical manufacturers will be closely watching.
Drug pricing policies, M&A oversight, FDA and HHS leadership, the Biosecure Act and tariffs are among the many issues pharmaceutical manufacturers will be closely watching.